Halozyme Therapeutics, Inc.
Calls20
Followers 0
- All Calls
- Financials
- Company details
2025
| Q1 | 2025 | 5/6 | 08:30 PM | Pending |
2024
| Q4 | 2024 | 2/18 | 09:30 PM | Pending |
| Q3 | 2024 | 10/31 | 08:30 PM | Pending |
| Q2 | 2024 | 8/6 | 08:30 PM | Pending |
| Q1 | 2024 | 5/7 | 08:30 PM | Pending |
2023
| Q4 | 2023 | 2/20 | 09:30 PM | Pending |
| Q3 | 2023 | 11/6 | 09:30 PM | Pending |
| Q2 | 2023 | 8/8 | 08:30 PM | Pending |
| Q1 | 2023 | 5/9 | 08:30 PM | Pending |
2022
| Q4 | 2022 | 2/21 | 09:30 PM | Pending |
| Q3 | 2022 | 11/8 | 09:30 PM | Pending |
| Q2 | 2022 | 8/9 | 08:30 PM | Pending |
| Q1 | 2022 | 5/10 | 08:30 PM | Pending |
2021
| Q4 | 2021 | 2/22 | 09:30 PM | Pending |
| Q3 | 2021 | 11/2 | 08:30 PM | Pending |
| Q2 | 2021 | 8/9 | 08:30 PM | Pending |
| Q1 | 2021 | 5/10 | 08:30 PM | Pending |
2020
| Q4 | 2020 | 2/23 | 09:30 PM | Pending |
| Q3 | 2020 | 11/2 | 09:30 PM | Awaiting Approval |
| Q2 | 2020 | 8/10 | 01:30 PM | Pending |